Director/PDMR Shareholding
19 December 2024
Helios Towers plc
Notification of dealings by a person discharging managerial responsibilities ("PDMR")
Helios Towers plc ("the Company") announces that Richard Byrne, a Director and PDMR of the Company, has transferred shares held in his own name to RBIT2024, LLC. This announcement is made in accordance with the requirements of Article 19(3) of the UK Market Abuse Regulation.
Enquiries: | |
For investor enquiries | |
For media enquiries | Edward Bridges, Rob Mindell |
| FTI Consulting LLP |
| +44 (0)20 3727 1000 |
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMR)
1 | Details of the person discharging managerial responsibilities / persons closely associated | |||||
a) | Name | Richard Byrne | ||||
2 | Reason for the notification | |||||
a) | Position/status | A Director and PDMR of the Company | ||||
b) | Initial notification/Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Helios Towers plc | ||||
b) | LEI | 213800DGC7GS4XCHCU30 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of GBP 0.01 in Helios Towers plc
GB00BJVQC708 | ||||
b) | Nature of the transaction | Transfer of ordinary shares to RBIT2024, LLC | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price
|
720,219
GBP 0.00 | ||||
e) | Date of the transaction | 18 December 2024 | ||||
f) | Place of the transaction | Outside of a trading venue | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.